New blood test aims to spot pancreatic cancer before It's too late

NCT ID NCT06388967

Recruiting now Diagnosis Sponsor: City of Hope Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study is testing a new blood test called PANXEON that looks for tiny genetic particles (miRNAs) to detect pancreatic cancer early. Researchers will collect blood samples from 2,000 people—some with pancreatic cancer and some without—to see how accurate the test is. If it works, it could lead to a simple, noninvasive way to catch this deadly cancer sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PANXEON blood test (measures miRNAs in blood samples)
What this could lead to: If successful, this blood test could help doctors detect pancreatic cancer earlier, when it is more treatable, potentially improving survival rates.
What could go wrong: This is a validation study, not a treatment trial. The test may not be accurate enough for widespread use, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

exocrine pancreatic carcinoma malignant pancreatic neoplasm pancreatic adenocarcinoma Pancreatic cancer, adult pancreatic ductal adenocarcinoma pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC ADENOCARCINOMA PANCREATIC CANCER PANCREATIC CANCER NON-RESECTABLE PANCREATIC CANCER RESECTABLE PANCREATIC CANCER STAGE PANCREATIC CANCER STAGE 0 PANCREATIC CANCER STAGE I PANCREATIC CANCER STAGE II PANCREATIC CANCER STAGE III PANCREATIC CANCER, ADULT PANCREATIC CARCINOMA PANCREATIC DUCTAL ADENOCARCINOMA PANCREATIC NEOPLASMS

Contacts and locations

Locations

Asan Medical Center
RECRUITING

Seoul, South Korea
Atlantic Health System
RECRUITING

Morristown, New Jersey, 07960, United States
City of Hope Medical Center
RECRUITING

Monrovia, California, 91016, United States
Hoag Center
RECRUITING

Newport Beach, California, 92663, United States
Honorhealth
RECRUITING

Scottsdale, Arizona, 85258, United States
Medical College of Wisconsin
RECRUITING

Milwaukee, Wisconsin, 53226, United States
Nagoya University
RECRUITING

Nagoya, Japan
OSF HealthCare
RECRUITING

Peoria, Illinois, 61637, United States
Ochsner Medical Center
RECRUITING

Jefferson, Louisiana, 70121, United States
Piedmont Medical Center
RECRUITING

Rock Hill, South Carolina, 29732, United States
Translational Genomics Research Institute
RECRUITING

Phoenix, Arizona, 85004, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.